May 22, 2023

Skyepharma study indicates new ways to control lag time API release in press-coated tablets

Oral dosage specialist CDMO Skyepharma Productions S.A.S. (Skyepharma) has collaborated with Bordeaux University to study the influence of geometrical and process parameters on the release attributes of press-coated tablets. The work potentially enables oral solid dose (OSD) forms to vary lag-time ingredient release profiles while retaining a constant formulation.

Key points for the study:

*Influence of process parameters

*Observing opening modes

*Alternative drug release adjustment

Full news available here.

To know more about controlled release, request access to our webinar replay on tab-in-tab formulations on STYL’One Evo

Access webinar replay

#controlled release #lag-time #release kinetics #press-coated tablets #OSD